Nuclear Medicine Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Nuclear Medicine market size was valued at USD 6368.4 million in 2022 and is forecast to a readjusted size of USD 10280 million by 2029 with a CAGR of 7.1% during review period.

Nuclear Medicine, or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second-place consumption region with the consumption market share of about 25%. Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share. The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%. Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.

This report is a detailed and comprehensive analysis for global Nuclear Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Nuclear Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nuclear Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nuclear Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nuclear Medicine market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Nuclear Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   GE Healthcare
   Bracco Imaging
   Mallinckrodt
   Lantheus Medical Imaging
   Bayer
   Triad Isotopes
   Nordion
   Jubilant Pharma
   Eli Lilly
   SIEMENS
   China Isotope & Radiation
   Dongcheng

   Tc-99
   I-123/131
   In-111
   Xe-133
   Th-201
   Ga-67
   Others

   Diagnostic
   Therapeutic

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Nuclear Medicine Market in 2025?

The Nuclear Medicine Market benefits from technological advancements in imaging and radiopharmaceuticals, improving diagnosis and treatment accuracy. Increased adoption of personalized medicine and molecular imaging also strengthens its growth. A growing aging population with chronic diseases further supports demand.

What are the weaknesses in the Nuclear Medicine Market in 2025?

The market faces challenges related to the high cost of equipment and treatments, limiting accessibility. The shortage of skilled professionals to operate advanced technologies can hinder market expansion. Additionally, regulatory barriers and safety concerns about radiation exposure remain persistent issues.

What opportunities exist for the Nuclear Medicine Market in 2025?

There are significant opportunities in expanding the use of nuclear medicine for early disease detection, especially in oncology, cardiology, and neurology. The rise of theranostics—treating and diagnosing using the same agent—presents innovative potential for targeted therapies. Further global market expansion, particularly in emerging economies, also offers substantial growth.

What threats are present in the Nuclear Medicine Market in 2025?

The market faces competition from alternative diagnostic and therapeutic methods, such as genetic testing and AI-based imaging. Economic factors like healthcare budget cuts and the cost-efficiency of nuclear medicine treatments may reduce demand. Additionally, any unforeseen radiation safety concerns or public skepticism could negatively impact market growth.

What are the political factors influencing the Nuclear Medicine Market in 2025?

Political stability and government healthcare policies play a crucial role in the market. Funding for healthcare infrastructure, research grants, and regulation of radiopharmaceuticals will affect market growth. Additionally, international collaborations for nuclear medicine research can lead to more standardized treatment protocols and regulations.

How do economic factors impact the Nuclear Medicine Market in 2025?

Economic conditions, such as healthcare budgets and the affordability of advanced treatments, directly influence the growth of nuclear medicine. High treatment costs may limit accessibility in low-income regions, while economic downturns could lead to reduced healthcare spending. However, long-term cost savings through early disease detection can drive market growth.

What social factors are affecting the Nuclear Medicine Market in 2025?

As awareness about nuclear medicine’s effectiveness grows, there is increased patient demand for advanced diagnostic and therapeutic treatments. Social acceptance of radiation-based treatments remains a challenge, particularly in regions where there are cultural concerns regarding radiation exposure. Aging populations globally will increase demand for nuclear medicine treatments.

How do technological factors influence the Nuclear Medicine Market in 2025?

Advancements in imaging technologies, such as PET and SPECT, enhance the precision of nuclear medicine treatments. The development of new radiopharmaceuticals for targeted therapy, particularly in oncology, and the use of AI in diagnosis are critical drivers of market innovation. Technological breakthroughs in theranostics are expected to further revolutionize the field.

What environmental factors affect the Nuclear Medicine Market in 2025?

The environmental impact of nuclear medicine, particularly the disposal of radioactive materials, requires strict regulations and waste management protocols. Growing environmental concerns could lead to heightened scrutiny and the development of more eco-friendly practices in production and disposal. Additionally, supply chain disruptions in the production of radiopharmaceuticals may arise due to environmental factors.

What legal factors are relevant to the Nuclear Medicine Market in 2025?

Strict regulations surrounding the use of radioactive materials and nuclear safety standards are vital for the market’s growth. Laws related to intellectual property protection of radiopharmaceutical innovations, as well as safety protocols for handling radiation, will shape the industry's future. Additionally, international regulations and cross-border collaborations will affect global market dynamics.

Who are the suppliers in the Nuclear Medicine Market in 2025?

Suppliers include manufacturers of radiopharmaceuticals, medical imaging devices (e.g., PET and SPECT scanners), and equipment for radiation safety. Key suppliers also encompass the producers of raw materials for radiopharmaceutical production, such as isotopes and other chemicals, as well as specialized research and development firms.

What are the inputs required in the Nuclear Medicine Market in 2025?

Inputs include highly specialized equipment for imaging and treatment, radiopharmaceuticals (both diagnostic and therapeutic), skilled labor (nuclear medicine specialists, radiologists, and technicians), and significant investment in research and development. Additionally, regulatory compliance and safety protocols are essential inputs in this field.

What processes are involved in the Nuclear Medicine Market in 2025?

Processes include the development, production, and distribution of radiopharmaceuticals, imaging procedures such as PET and SPECT scans, the administration of radiation therapy, and ongoing patient monitoring. Collaboration between medical professionals, research institutions, and healthcare providers ensures that treatment protocols are followed and innovations are integrated.

Who are the customers in the Nuclear Medicine Market in 2025?

Customers include healthcare providers such as hospitals, diagnostic clinics, and oncology centers that offer nuclear medicine services. Patients requiring diagnostic imaging for conditions like cancer, heart disease, and neurological disorders are key end-users. Research institutions also represent an important customer group for new radiopharmaceuticals and treatment technologies.

What are the outputs of the Nuclear Medicine Market in 2025?

Outputs include advanced diagnostic imaging reports, successful radiation therapy treatments, new radiopharmaceuticals for targeted therapies, and research findings that contribute to the evolution of the field. These outputs are designed to enhance patient care through early disease detection, treatment precision, and personalized medicine approaches.

What is the threat of new entrants in the Nuclear Medicine Market in 2025?

The threat of new entrants is relatively low due to high entry barriers, such as the significant capital investment required for specialized equipment, regulatory approvals, and the need for skilled professionals. Additionally, the complexity of developing radiopharmaceuticals and the expertise required to handle radioactive materials makes it challenging for new players to enter the market.

How intense is the bargaining power of suppliers in the Nuclear Medicine Market in 2025?

The bargaining power of suppliers is moderate to high. Key suppliers of raw materials for radiopharmaceuticals, medical imaging devices, and isotopes control critical resources needed in the production process. However, the growth of alternative suppliers and international collaborations can reduce the influence of any single supplier over time.

What is the bargaining power of buyers in the Nuclear Medicine Market in 2025?

The bargaining power of buyers is moderate. Healthcare providers and institutions often rely on advanced nuclear medicine technology, but they have limited options when it comes to high-quality, effective radiopharmaceuticals and imaging devices. However, as more innovative solutions enter the market, buyers may gain some leverage to negotiate pricing and services.

How intense is the threat of substitutes in the Nuclear Medicine Market in 2025?

The threat of substitutes is moderate. While alternative diagnostic and therapeutic methods, such as genetic testing, AI-based imaging, and non-radiation therapies, are emerging, nuclear medicine still provides unique benefits, particularly in early disease detection and targeted treatments. Substitutes could pose a threat, but nuclear medicine remains a critical and irreplaceable part of certain treatment protocols.

How competitive is the Nuclear Medicine Market in 2025?

The Nuclear Medicine Market is highly competitive. There are established players, including large healthcare companies, radiopharmaceutical manufacturers, and imaging device producers, all vying for market share. Continuous innovation in radiopharmaceuticals, imaging technologies, and therapeutic treatments, combined with regulatory hurdles and pricing pressures, intensifies competition in the market.

What are the key upstream components in the Nuclear Medicine Market in 2025?

Key upstream components include the production of radiopharmaceuticals, the supply of isotopes, and the manufacturing of medical imaging devices such as PET and SPECT scanners. Research and development activities to discover new radiopharmaceuticals and diagnostic technologies are also integral to the upstream segment of the market.

What are the major suppliers in the upstream segment of the Nuclear Medicine Market?

Major suppliers include manufacturers of medical imaging equipment, such as GE Healthcare and Siemens, and companies specializing in radiopharmaceuticals, like Bayer and Eli Lilly. Suppliers of radioactive isotopes, like nuclear reactors or cyclotrons, as well as specialized suppliers of chemicals and materials used in radiopharmaceutical production, also play a significant role.

What are the challenges faced in the upstream segment of the Nuclear Medicine Market?

Challenges in the upstream segment include the high cost of producing radiopharmaceuticals, which requires significant investment in facilities, technology, and regulatory compliance. Additionally, the limited availability of certain isotopes, the complexity of supply chains, and the need for stringent safety and environmental protocols add further difficulty. The specialized nature of the required equipment and expertise also limits the number of potential suppliers.

How does regulation affect the upstream segment of the Nuclear Medicine Market?

Regulation has a significant impact on the upstream segment. Manufacturers must comply with strict safety, quality control, and radiation handling standards set by regulatory bodies like the FDA and EMA. These regulations affect the production processes, distribution, and disposal of radioactive materials, and any changes to these laws can impact costs and supply chains.

What technological advancements are influencing the upstream segment of the Nuclear Medicine Market?

Technological advancements in imaging devices, such as higher-resolution PET and SPECT scanners, are driving innovation in the upstream segment. Additionally, advancements in radiopharmaceutical production, such as the development of targeted therapy agents and the improvement of isotope production techniques, are enabling more effective treatments and diagnostic solutions. The development of cyclotron technology and artificial intelligence is also influencing the market by improving the precision and speed of diagnostics and treatment planning.

What are the key activities in the midstream segment of the Nuclear Medicine Market in 2025?

Key activities in the midstream segment include the distribution and logistics of radiopharmaceuticals and medical imaging devices to healthcare facilities. This involves ensuring the timely delivery of isotopes, handling regulatory compliance during transportation, and maintaining proper storage conditions, particularly for temperature-sensitive products.

Who are the major players in the midstream segment of the Nuclear Medicine Market?

Major players in the midstream segment include logistics companies specializing in the transportation of radioactive materials, such as Nuclear Logistics Inc. and Curium Pharma. Additionally, large healthcare distributors like McKesson and Cardinal Health play a key role in delivering radiopharmaceuticals and imaging devices to hospitals, clinics, and diagnostic centers.

What are the challenges faced in the midstream segment of the Nuclear Medicine Market?

Challenges in the midstream segment include managing the complex and time-sensitive nature of radiopharmaceutical distribution, particularly due to the short shelf life of certain isotopes. Regulatory compliance across different regions and ensuring the safety of radioactive materials during transport are additional hurdles. Furthermore, maintaining the required storage conditions and managing potential supply chain disruptions can impact the market.

How does regulation impact the midstream segment of the Nuclear Medicine Market?

Regulation heavily influences the midstream segment, particularly in the transportation and storage of radioactive materials. Compliance with safety standards set by regulatory bodies like the FDA, EPA, and IAEA is crucial. These regulations affect packaging, handling, and the training of personnel involved in the transportation of radiopharmaceuticals to ensure safety and minimize environmental risk.

What technological advancements are influencing the midstream segment of the Nuclear Medicine Market?

Technological advancements in tracking and monitoring systems, such as real-time GPS tracking and temperature-sensitive packaging, are enhancing the efficiency and safety of the midstream segment. Automation and data analytics are being applied to optimize logistics and inventory management. These innovations help reduce errors, improve the timeliness of deliveries, and ensure the safe handling of radiopharmaceuticals.

What are the key activities in the downstream segment of the Nuclear Medicine Market in 2025?

Key activities in the downstream segment include the administration of nuclear medicine treatments, diagnostic imaging procedures, and patient monitoring. Healthcare providers, such as hospitals, oncology centers, and diagnostic clinics, are responsible for delivering these services to patients, interpreting imaging results, and providing follow-up care.

Who are the major players in the downstream segment of the Nuclear Medicine Market?

Major players in the downstream segment include healthcare providers such as hospitals, specialized oncology and cardiology centers, and diagnostic clinics. Notable imaging facilities and radiology centers that offer nuclear imaging services also play a significant role. Additionally, pharmaceutical companies that develop radiopharmaceuticals for therapeutic and diagnostic use are involved in the downstream activities.

What are the challenges faced in the downstream segment of the Nuclear Medicine Market?

Challenges in the downstream segment include the high cost of treatments and the limited availability of certain advanced imaging technologies, which can restrict access for patients. The shortage of skilled professionals to operate nuclear medicine equipment and interpret complex imaging results is also a concern. Additionally, the need to maintain strict radiation safety protocols and manage potential side effects can complicate operations.

How does regulation impact the downstream segment of the Nuclear Medicine Market?

Regulation plays a significant role in ensuring patient safety and the effective use of nuclear medicine. Regulatory bodies require healthcare providers to adhere to radiation safety standards, proper training, and certification for medical professionals involved in nuclear medicine procedures. These regulations affect the way services are delivered and impact the types of treatments available to patients.

What technological advancements are influencing the downstream segment of the Nuclear Medicine Market?

Technological advancements in imaging technologies, such as improved PET and SPECT scanners, are enhancing diagnostic capabilities. The development of precision medicine and theranostics, which combine diagnostic imaging and targeted therapies, is also transforming the downstream segment. Additionally, advancements in AI for interpreting medical images and improving patient outcomes are making a significant impact on the efficiency and accuracy of nuclear medicine treatments.

Chapter 1, to describe Nuclear Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nuclear Medicine, with revenue, gross margin and global market share of Nuclear Medicine from 2018 to 2023.
Chapter 3, the Nuclear Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nuclear Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nuclear Medicine.
Chapter 13, to describe Nuclear Medicine research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Nuclear Medicine
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Nuclear Medicine by Type
       1.3.1 Overview: Global Nuclear Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Nuclear Medicine Consumption Value Market Share by Type in 2022
       1.3.3 Tc-99
       1.3.4 I-123/131
       1.3.5 In-111
       1.3.6 Xe-133
       1.3.7 Th-201
       1.3.8 Ga-67
       1.3.9 Others
   1.4 Global Nuclear Medicine Market by Application
       1.4.1 Overview: Global Nuclear Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Diagnostic
       1.4.3 Therapeutic
   1.5 Global Nuclear Medicine Market Size & Forecast
   1.6 Global Nuclear Medicine Market Size and Forecast by Region
       1.6.1 Global Nuclear Medicine Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Nuclear Medicine Market Size by Region, (2018-2029)
       1.6.3 North America Nuclear Medicine Market Size and Prospect (2018-2029)
       1.6.4 Europe Nuclear Medicine Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Nuclear Medicine Market Size and Prospect (2018-2029)
       1.6.6 South America Nuclear Medicine Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Nuclear Medicine Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 GE Healthcare
       2.1.1 GE Healthcare Details
       2.1.2 GE Healthcare Major Business
       2.1.3 GE Healthcare Nuclear Medicine Product and Solutions
       2.1.4 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 GE Healthcare Recent Developments and Future Plans
   2.2 Bracco Imaging
       2.2.1 Bracco Imaging Details
       2.2.2 Bracco Imaging Major Business
       2.2.3 Bracco Imaging Nuclear Medicine Product and Solutions
       2.2.4 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Bracco Imaging Recent Developments and Future Plans
   2.3 Mallinckrodt
       2.3.1 Mallinckrodt Details
       2.3.2 Mallinckrodt Major Business
       2.3.3 Mallinckrodt Nuclear Medicine Product and Solutions
       2.3.4 Mallinckrodt Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Mallinckrodt Recent Developments and Future Plans
   2.4 Lantheus Medical Imaging
       2.4.1 Lantheus Medical Imaging Details
       2.4.2 Lantheus Medical Imaging Major Business
       2.4.3 Lantheus Medical Imaging Nuclear Medicine Product and Solutions
       2.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Lantheus Medical Imaging Recent Developments and Future Plans
   2.5 Bayer
       2.5.1 Bayer Details
       2.5.2 Bayer Major Business
       2.5.3 Bayer Nuclear Medicine Product and Solutions
       2.5.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Bayer Recent Developments and Future Plans
   2.6 Triad Isotopes
       2.6.1 Triad Isotopes Details
       2.6.2 Triad Isotopes Major Business
       2.6.3 Triad Isotopes Nuclear Medicine Product and Solutions
       2.6.4 Triad Isotopes Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Triad Isotopes Recent Developments and Future Plans
   2.7 Nordion
       2.7.1 Nordion Details
       2.7.2 Nordion Major Business
       2.7.3 Nordion Nuclear Medicine Product and Solutions
       2.7.4 Nordion Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Nordion Recent Developments and Future Plans
   2.8 Jubilant Pharma
       2.8.1 Jubilant Pharma Details
       2.8.2 Jubilant Pharma Major Business
       2.8.3 Jubilant Pharma Nuclear Medicine Product and Solutions
       2.8.4 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Jubilant Pharma Recent Developments and Future Plans
   2.9 Eli Lilly
       2.9.1 Eli Lilly Details
       2.9.2 Eli Lilly Major Business
       2.9.3 Eli Lilly Nuclear Medicine Product and Solutions
       2.9.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Eli Lilly Recent Developments and Future Plans
   2.10 SIEMENS 
       2.10.1 SIEMENS Details
       2.10.2 SIEMENS Major Business
       2.10.3 SIEMENS Nuclear Medicine Product and Solutions
       2.10.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 SIEMENS Recent Developments and Future Plans
   2.11 China Isotope & Radiation
       2.11.1 China Isotope & Radiation Details
       2.11.2 China Isotope & Radiation Major Business
       2.11.3 China Isotope & Radiation Nuclear Medicine Product and Solutions
       2.11.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 China Isotope & Radiation Recent Developments and Future Plans
   2.12 Dongcheng
       2.12.1 Dongcheng Details
       2.12.2 Dongcheng Major Business
       2.12.3 Dongcheng Nuclear Medicine Product and Solutions
       2.12.4 Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Dongcheng Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Nuclear Medicine Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Nuclear Medicine by Company Revenue
       3.2.2 Top 3 Nuclear Medicine Players Market Share in 2022
       3.2.3 Top 6 Nuclear Medicine Players Market Share in 2022
   3.3 Nuclear Medicine Market: Overall Company Footprint Analysis
       3.3.1 Nuclear Medicine Market: Region Footprint
       3.3.2 Nuclear Medicine Market: Company Product Type Footprint
       3.3.3 Nuclear Medicine Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Nuclear Medicine Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Nuclear Medicine Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Nuclear Medicine Consumption Value Market Share by Application (2018-2023)
   5.2 Global Nuclear Medicine Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Nuclear Medicine Consumption Value by Type (2018-2029)
   6.2 North America Nuclear Medicine Consumption Value by Application (2018-2029)
   6.3 North America Nuclear Medicine Market Size by Country
       6.3.1 North America Nuclear Medicine Consumption Value by Country (2018-2029)
       6.3.2 United States Nuclear Medicine Market Size and Forecast (2018-2029)
       6.3.3 Canada Nuclear Medicine Market Size and Forecast (2018-2029)
       6.3.4 Mexico Nuclear Medicine Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Nuclear Medicine Consumption Value by Type (2018-2029)
   7.2 Europe Nuclear Medicine Consumption Value by Application (2018-2029)
   7.3 Europe Nuclear Medicine Market Size by Country
       7.3.1 Europe Nuclear Medicine Consumption Value by Country (2018-2029)
       7.3.2 Germany Nuclear Medicine Market Size and Forecast (2018-2029)
       7.3.3 France Nuclear Medicine Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Nuclear Medicine Market Size and Forecast (2018-2029)
       7.3.5 Russia Nuclear Medicine Market Size and Forecast (2018-2029)
       7.3.6 Italy Nuclear Medicine Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Nuclear Medicine Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Nuclear Medicine Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Nuclear Medicine Market Size by Region
       8.3.1 Asia-Pacific Nuclear Medicine Consumption Value by Region (2018-2029)
       8.3.2 China Nuclear Medicine Market Size and Forecast (2018-2029)
       8.3.3 Japan Nuclear Medicine Market Size and Forecast (2018-2029)
       8.3.4 South Korea Nuclear Medicine Market Size and Forecast (2018-2029)
       8.3.5 India Nuclear Medicine Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Nuclear Medicine Market Size and Forecast (2018-2029)
       8.3.7 Australia Nuclear Medicine Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Nuclear Medicine Consumption Value by Type (2018-2029)
   9.2 South America Nuclear Medicine Consumption Value by Application (2018-2029)
   9.3 South America Nuclear Medicine Market Size by Country
       9.3.1 South America Nuclear Medicine Consumption Value by Country (2018-2029)
       9.3.2 Brazil Nuclear Medicine Market Size and Forecast (2018-2029)
       9.3.3 Argentina Nuclear Medicine Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Nuclear Medicine Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Nuclear Medicine Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Nuclear Medicine Market Size by Country
       10.3.1 Middle East & Africa Nuclear Medicine Consumption Value by Country (2018-2029)
       10.3.2 Turkey Nuclear Medicine Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Nuclear Medicine Market Size and Forecast (2018-2029)
       10.3.4 UAE Nuclear Medicine Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Nuclear Medicine Market Drivers
   11.2 Nuclear Medicine Market Restraints
   11.3 Nuclear Medicine Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Nuclear Medicine Industry Chain
   12.2 Nuclear Medicine Upstream Analysis
   12.3 Nuclear Medicine Midstream Analysis
   12.4 Nuclear Medicine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Nuclear Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Nuclear Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Nuclear Medicine Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Nuclear Medicine Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. GE Healthcare Company Information, Head Office, and Major Competitors
   Table 6. GE Healthcare Major Business
   Table 7. GE Healthcare Nuclear Medicine Product and Solutions
   Table 8. GE Healthcare Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. GE Healthcare Recent Developments and Future Plans
   Table 10. Bracco Imaging Company Information, Head Office, and Major Competitors
   Table 11. Bracco Imaging Major Business
   Table 12. Bracco Imaging Nuclear Medicine Product and Solutions
   Table 13. Bracco Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Bracco Imaging Recent Developments and Future Plans
   Table 15. Mallinckrodt Company Information, Head Office, and Major Competitors
   Table 16. Mallinckrodt Major Business
   Table 17. Mallinckrodt Nuclear Medicine Product and Solutions
   Table 18. Mallinckrodt Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Mallinckrodt Recent Developments and Future Plans
   Table 20. Lantheus Medical Imaging Company Information, Head Office, and Major Competitors
   Table 21. Lantheus Medical Imaging Major Business
   Table 22. Lantheus Medical Imaging Nuclear Medicine Product and Solutions
   Table 23. Lantheus Medical Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Lantheus Medical Imaging Recent Developments and Future Plans
   Table 25. Bayer Company Information, Head Office, and Major Competitors
   Table 26. Bayer Major Business
   Table 27. Bayer Nuclear Medicine Product and Solutions
   Table 28. Bayer Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Bayer Recent Developments and Future Plans
   Table 30. Triad Isotopes Company Information, Head Office, and Major Competitors
   Table 31. Triad Isotopes Major Business
   Table 32. Triad Isotopes Nuclear Medicine Product and Solutions
   Table 33. Triad Isotopes Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Triad Isotopes Recent Developments and Future Plans
   Table 35. Nordion Company Information, Head Office, and Major Competitors
   Table 36. Nordion Major Business
   Table 37. Nordion Nuclear Medicine Product and Solutions
   Table 38. Nordion Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Nordion Recent Developments and Future Plans
   Table 40. Jubilant Pharma Company Information, Head Office, and Major Competitors
   Table 41. Jubilant Pharma Major Business
   Table 42. Jubilant Pharma Nuclear Medicine Product and Solutions
   Table 43. Jubilant Pharma Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Jubilant Pharma Recent Developments and Future Plans
   Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
   Table 46. Eli Lilly Major Business
   Table 47. Eli Lilly Nuclear Medicine Product and Solutions
   Table 48. Eli Lilly Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Eli Lilly Recent Developments and Future Plans
   Table 50. SIEMENS Company Information, Head Office, and Major Competitors
   Table 51. SIEMENS Major Business
   Table 52. SIEMENS Nuclear Medicine Product and Solutions
   Table 53. SIEMENS Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. SIEMENS Recent Developments and Future Plans
   Table 55. China Isotope & Radiation Company Information, Head Office, and Major Competitors
   Table 56. China Isotope & Radiation Major Business
   Table 57. China Isotope & Radiation Nuclear Medicine Product and Solutions
   Table 58. China Isotope & Radiation Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. China Isotope & Radiation Recent Developments and Future Plans
   Table 60. Dongcheng Company Information, Head Office, and Major Competitors
   Table 61. Dongcheng Major Business
   Table 62. Dongcheng Nuclear Medicine Product and Solutions
   Table 63. Dongcheng Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Dongcheng Recent Developments and Future Plans
   Table 65. Global Nuclear Medicine Revenue (USD Million) by Players (2018-2023)
   Table 66. Global Nuclear Medicine Revenue Share by Players (2018-2023)
   Table 67. Breakdown of Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 68. Market Position of Players in Nuclear Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 69. Head Office of Key Nuclear Medicine Players
   Table 70. Nuclear Medicine Market: Company Product Type Footprint
   Table 71. Nuclear Medicine Market: Company Product Application Footprint
   Table 72. Nuclear Medicine New Market Entrants and Barriers to Market Entry
   Table 73. Nuclear Medicine Mergers, Acquisition, Agreements, and Collaborations
   Table 74. Global Nuclear Medicine Consumption Value (USD Million) by Type (2018-2023)
   Table 75. Global Nuclear Medicine Consumption Value Share by Type (2018-2023)
   Table 76. Global Nuclear Medicine Consumption Value Forecast by Type (2024-2029)
   Table 77. Global Nuclear Medicine Consumption Value by Application (2018-2023)
   Table 78. Global Nuclear Medicine Consumption Value Forecast by Application (2024-2029)
   Table 79. North America Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
   Table 80. North America Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
   Table 81. North America Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
   Table 82. North America Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
   Table 83. North America Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
   Table 84. North America Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
   Table 85. Europe Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
   Table 86. Europe Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
   Table 87. Europe Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
   Table 88. Europe Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
   Table 89. Europe Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
   Table 92. Asia-Pacific Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
   Table 93. Asia-Pacific Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
   Table 94. Asia-Pacific Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
   Table 95. Asia-Pacific Nuclear Medicine Consumption Value by Region (2018-2023) & (USD Million)
   Table 96. Asia-Pacific Nuclear Medicine Consumption Value by Region (2024-2029) & (USD Million)
   Table 97. South America Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
   Table 98. South America Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
   Table 99. South America Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
   Table 100. South America Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
   Table 101. South America Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
   Table 102. South America Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
   Table 103. Middle East & Africa Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
   Table 104. Middle East & Africa Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
   Table 105. Middle East & Africa Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
   Table 106. Middle East & Africa Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
   Table 108. Middle East & Africa Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
   Table 109. Nuclear Medicine Raw Material
   Table 110. Key Suppliers of Nuclear Medicine Raw Materials

List of Figures

   Figure 1. Nuclear Medicine Picture
   Figure 2. Global Nuclear Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Nuclear Medicine Consumption Value Market Share by Type in 2022
   Figure 4. Tc-99
   Figure 5. I-123/131
   Figure 6. In-111
   Figure 7. Xe-133
   Figure 8. Th-201
   Figure 9. Ga-67
   Figure 10. Others
   Figure 11. Global Nuclear Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 12. Nuclear Medicine Consumption Value Market Share by Application in 2022
   Figure 13. Diagnostic Picture
   Figure 14. Therapeutic Picture
   Figure 15. Global Nuclear Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 16. Global Nuclear Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 17. Global Market Nuclear Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 18. Global Nuclear Medicine Consumption Value Market Share by Region (2018-2029)
   Figure 19. Global Nuclear Medicine Consumption Value Market Share by Region in 2022
   Figure 20. North America Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 21. Europe Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 22. Asia-Pacific Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 23. South America Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 24. Middle East and Africa Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 25. Global Nuclear Medicine Revenue Share by Players in 2022
   Figure 26. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 27. Global Top 3 Players Nuclear Medicine Market Share in 2022
   Figure 28. Global Top 6 Players Nuclear Medicine Market Share in 2022
   Figure 29. Global Nuclear Medicine Consumption Value Share by Type (2018-2023)
   Figure 30. Global Nuclear Medicine Market Share Forecast by Type (2024-2029)
   Figure 31. Global Nuclear Medicine Consumption Value Share by Application (2018-2023)
   Figure 32. Global Nuclear Medicine Market Share Forecast by Application (2024-2029)
   Figure 33. North America Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
   Figure 34. North America Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
   Figure 35. North America Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
   Figure 36. United States Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 37. Canada Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 38. Mexico Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 39. Europe Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
   Figure 40. Europe Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
   Figure 41. Europe Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
   Figure 42. Germany Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 43. France Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 44. United Kingdom Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 45. Russia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 46. Italy Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 47. Asia-Pacific Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
   Figure 48. Asia-Pacific Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
   Figure 49. Asia-Pacific Nuclear Medicine Consumption Value Market Share by Region (2018-2029)
   Figure 50. China Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 51. Japan Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 52. South Korea Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 53. India Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 54. Southeast Asia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 55. Australia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 56. South America Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
   Figure 57. South America Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
   Figure 58. South America Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
   Figure 59. Brazil Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 60. Argentina Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 61. Middle East and Africa Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
   Figure 62. Middle East and Africa Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
   Figure 63. Middle East and Africa Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
   Figure 64. Turkey Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 65. Saudi Arabia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 66. UAE Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
   Figure 67. Nuclear Medicine Market Drivers
   Figure 68. Nuclear Medicine Market Restraints
   Figure 69. Nuclear Medicine Market Trends
   Figure 70. Porters Five Forces Analysis
   Figure 71. Manufacturing Cost Structure Analysis of Nuclear Medicine in 2022
   Figure 72. Manufacturing Process Analysis of Nuclear Medicine
   Figure 73. Nuclear Medicine Industrial Chain
   Figure 74. Methodology
   Figure 75. Research Process and Data Source